Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05010642 · ClinicalTrials.gov registry record
Low Ejection Fraction in Single Lead ECG- Ochsner
A clinical trial, sponsored by Eko Devices.
- Completed
- Registry status
- 307
- Enrollment target
NCT05010642: Completed study, sponsored by Eko Devices.
NCT05010642 is a clinical trial that has completed, run by Eko Devices. The registered enrollment target is 307 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05010642 has completed, sponsored by Eko Devices.
- COMPLETED
- Registry status
- 307 participants
- Enrollment target
Study Summary
The purpose of this research is to prospectively test and validate the single-lead Low EF algorithm in outpatients in order to test the performance of a single-lead ECG based algorithm to identify people with decreased left ventricular EF.
Primary Outcome
Evaluate performance of single-lead ECG based algorithm to identify individuals with reduced ejection fraction.
Interventions
- DEVICE Use of Eko DUO electronic Stethoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2021-08-19 |
| Est. Completion | 2022-04-29 |
What the finished NCT05010642 record still lists
NCT05010642 is an observational study that tracks outcomes without assigning an intervention. The registered 307 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Use of Eko DUO electronic Stethoscope is the first listed.
NCT05010642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05010642 about?
NCT05010642 is a clinical study titled "Low Ejection Fraction in Single Lead ECG- Ochsner". The purpose of this research is to prospectively test and validate the single-lead Low EF algorithm in outpatients in order to test the performance of a single-lead ECG based algorithm to identify people with decreased left ventricular EF.
What is the current status of trial NCT05010642?
This trial is currently completed. The enrollment target is 307 participants. The study started on 2021-08-19. Estimated completion is 2022-04-29.
What interventions are being tested in trial NCT05010642?
The interventions under investigation include: Use of Eko DUO electronic Stethoscope (DEVICE).
Who is sponsoring clinical trial NCT05010642?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05433142 · 307 participants · Phase 1
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- NCT04162938 · 308 participants · NA
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- NCT04955795 · 308 participants · NA
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
- NCT06090539 · 308 participants · Phase 1
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI